Specific splicing regulatory protein human hTra2-beta but not hTra2-alpha is overexpressed in invasive human breast cancer.

E. Stickeler,D. Watermann,S. Stamm,I. Runnebaum
DOI: https://doi.org/10.1200/JCO.2004.22.14_SUPPL.9621
IF: 45.3
2004-07-15
Journal of Clinical Oncology
Abstract:9621 Background: The two human dTra2 orthologs hTra2-alpha and hTra2-beta 1, members of the extended family of serine-argenine-rich (SR) splicingfactors, regulate alternative splicing of exons with C/A-rich enhancer sequences. The CD44 gene, encoding for an extracellular matrix protein, undergoes extensive alternative splicing of at least 10 variable exons. Alternative exons v4-v6 which contain these C/A-rich enhancer sequences have increased inclusion levels in breast cancer. They are thought to be involved in tumor progression and metastasis. Recently, we demonstrated that alternative exon v4 inclusion is increased upon over-expression of the DNA and RNA binding protein YB-1 and Tra2 in a mouse model of breast cancer development. MATERIAL AND METHODS In this study we investigated expression levels of hTRa2-alpha and hTra2-beta 1 in a matched pair analysis of tumor samples and normal tissues of patients with invasive breast cancer by Western Blot and RT-PCR analysis. In addition, we performed in vivo splicing assays to examine the functional effects of human Tra2 on CD44 splicing. RESULTS Western Blot and RT-PCR revealed a marked induction of hTra2-beta 1 but not - hTra2-alpha expression in adenocarcinomas of the breast in comparison to physiological tissue samples of the same patient. The in vivo splicing assays showed, that human Tra2 specifically affected the in vivo inclusion of CD44 exon v4. CONCLUSIONS Our results suggest that involvement of hTra2 in CD44 exon recognition and alternative splicing may be important to over-expression of these CD44 alternative protein isoforms in invasive breast cancer leading to tumor progression and metastasis No significant financial relationships to disclose.
What problem does this paper attempt to address?